Zerigo Health

Zerigo Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $63M

Overview

Zerigo Health is a San Diego-based digital health company founded in 2015, focused on the dermatology sector. It has developed the Zerigo Skin Health Program, a connected care platform centered on the first FDA-cleared portable narrowband UVB phototherapy device for at-home use. The platform aims to solve the significant access and adherence challenges of traditional in-office phototherapy by providing a convenient, personalized, and guided treatment experience. By offering a clinically effective alternative to expensive systemic drugs, Zerigo targets both patient outcomes and cost savings for payers and employers.

Dermatology

Technology Platform

Integrated digital health platform combining an FDA-cleared, portable narrowband UVB phototherapy device, a machine-learning-powered mobile app for personalized treatment tracking and adjustment, and dedicated human care guides for patient support.

Funding History

2
Total raised:$63M
Series B$43M
Series A$20M

Opportunities

Large addressable market driven by high prevalence of chronic skin conditions and escalating costs of biologic drugs, creating strong demand from payers for cost-effective alternatives.
The shift towards telehealth, remote patient monitoring, and value-based care aligns perfectly with Zerigo's connected, at-home care delivery model.

Risk Factors

Securing consistent and broad insurance reimbursement is a major hurdle.
The company faces competition from other phototherapy devices, in-office clinics, and entrenched pharmaceutical treatments.
Success requires changing established patient and physician behaviors and scaling complex B2B sales to payers.

Competitive Landscape

Zerigo competes with traditional in-office phototherapy clinics, other manufacturers of home phototherapy devices (often larger, non-connected units), and the broad pharmaceutical market for dermatology (topicals, systemics, and biologics). Its key differentiators are the FDA-cleared portable form factor, the integrated app for personalized dosing, and the wrap-around care guide support, positioning it as a comprehensive care platform rather than just a device.